Joel Kaufman

Joel Kaufman is an accomplished finance executive with extensive experience in the biotechnology and healthcare sectors. Currently serving as Chief Financial Officer at PrognomiQ Inc, a position held since December 2024, Kaufman previously held the same title at Haystack Oncology and has contributed to the financial strategy of companies such as Sema4 as Vice President of Finance & Corporate Development and Navidea Biopharmaceuticals as Chief Business Officer and Head of Corporate Strategy. Kaufman's career at Goldman Sachs included roles as an Equity Research Associate and Analyst in the medical technology and life sciences sectors. Academic credentials include an MBA from the Kellogg School of Management at Northwestern University and a BA in Neuroscience, Economics, and Healthcare Management from the University of Pennsylvania.